This incident of eosinophilic pneumonia occurred in (b)(6), and we are reporting this event to fda according to the requirement.Plasmaflo op-05w is similar model of plasmaflo op-05w(a) marketed in us.The actual used product was not returned to us for investigation and could not be analyzed, and the lot number was unknown.We have not received any event of eosinophilic pneumonia other than this case since we started selling plasmaflo op globally.Patient's physician considers that this case is serious event and that causal relationship between plasmaflo op and this event is possible, and the doctor whose hospital this patient was transferred to commented that this case is possibly related to iapp.We also consider the severity of eosinophilic pneumonia is serious injury as patient has hospitalized for the treatment of pneumonia and was given the treatment of mechanical ventilator, and the causal relationship between this device and the event could not be denied because the event happened just after iapp treatment.The caution for this event is not described in instruction for use, however this case is the first event happened on plasmaflo op, we will continue to vigilance trend in occurring this kind of event(eosinophilic pneumonia) with plasmaflo op.
|
A (b)(6) woman started the treatment with immunoadsorption plasmapheresis(iapp) of plasmaflo op-o5w and immusorba tr-350 for myasthenia gravis on (b)(6), and was given the treatment with iapp on (b)(6).On (b)(6) 2018, she was given the seventh treatment with iapp of plasmaflo op-o5w and immusorba tr-350 for myasthenia gravis.Just after catheter withdrawal, this patient experienced respiratory discomfort.Conclusion of air in her blood was suspected to have occurred, and chest x-ray was taken, which showed opacity like the diffuse pneumonia in her left lung.Soon after she returned to the hospital ward, her symptom worsened and oxygen was given via oxygen mask, but still she could not maintain her breathing, and she was given the treatment with ventilator.Acute respiratory distress syndrome(ards) was suspected, and she was given the treatment of antibiotic meropenem and elaspol, but she could not wean from mechanical ventilator.On (b)(6) 2018, this patient was admitted to another hospital, and was given the treatment with antifungal agent for allergic bronchopulmonary mycoses.In the end of march, she was given the conservative medical management.She has recovered and was discharged from the hospital.
|